Raymond James Financial Services Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.16M | Sell |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $2.23M | Sell |
|
|||||
|
2022
Q4 | $2.1M | Sell |
|
|||||
|
2022
Q3 | $2.46M | Buy |
|
|||||
|
2022
Q2 | $2.11M | Buy |
|
|||||
|
2022
Q1 | $2.45M | Sell |
|
|||||
|
2021
Q4 | $2.65M | Buy |
|
|||||
|
2021
Q3 | $2.25M | Buy |
|
|||||
|
2021
Q2 | $1.6M | Buy |
|
|||||
|
2021
Q1 | $1.66M | Buy |
|
|||||
|
2020
Q4 | $1.11M | Sell |
|
|||||
|
2020
Q3 | $2.2M | Sell |
|
|||||
|
2020
Q2 | $3.42M | Buy |
|
|||||
|
2020
Q1 | $3.43M | Buy |
|
|||||
|
2019
Q4 | $411K | Sell |
|
|||||
|
2019
Q3 | $435K | Buy |
|
|||||
|
2019
Q2 | $237K | Sell |
|
|||||
|
2019
Q1 | $367K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $697K | Buy |
|